B
Bailard’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $704K | Buy |
5,563
+2
| +0% | +$253 | 0.02% | 398 |
|
|
2025
Q1 | $711K | Buy |
5,561
+11
| +0.2% | +$1.41K | 0.02% | 373 |
|
|
2024
Q4 | $734K | Sell |
5,550
-3
| -0.1% | -$397 | 0.02% | 361 |
|
|
2024
Q3 | $809K | Hold |
5,553
| – | – | 0.02% | 342 |
|
|
2024
Q2 | $762K | Sell |
5,553
-240
| -4% | -$32.9K | 0.02% | 341 |
|
|
2024
Q1 | $795K | Sell |
5,793
-379
| -6% | -$52K | 0.02% | 342 |
|
|
2023
Q4 | $838K | Hold |
6,172
| – | – | 0.02% | 317 |
|
|
2023
Q3 | $755K | Sell |
6,172
-43
| -0.7% | -$5.26K | 0.03% | 317 |
|
|
2023
Q2 | $789K | Sell |
6,215
-116
| -2% | -$14.7K | 0.03% | 298 |
|
|
2023
Q1 | $818K | Sell |
6,331
-398
| -6% | -$51.4K | 0.03% | 296 |
|
|
2022
Q4 | $883K | Sell |
6,729
-38
| -0.6% | -$4.99K | 0.03% | 279 |
|
|
2022
Q3 | $791K | Sell |
6,767
-51
| -0.7% | -$5.96K | 0.03% | 271 |
|
|
2022
Q2 | $802K | Buy |
6,818
+61
| +0.9% | +$7.18K | 0.03% | 273 |
|
|
2022
Q1 | $880K | Sell |
6,757
-300
| -4% | -$39.1K | 0.03% | 283 |
|
|
2021
Q4 | $1.08M | Hold |
7,057
| – | – | 0.03% | 254 |
|
|
2021
Q3 | $1.14M | Buy |
7,057
+177
| +3% | +$28.6K | 0.04% | 251 |
|
|
2021
Q2 | $1.13M | Hold |
6,880
| – | – | 0.04% | 260 |
|
|
2021
Q1 | $1.04M | Buy |
6,880
+3,000
| +77% | +$452K | 0.04% | 256 |
|
|
2020
Q4 | $588K | Hold |
3,880
| – | – | 0.03% | 290 |
|
|
2020
Q3 | $525K | Hold |
3,880
| – | – | 0.03% | 273 |
|
|
2020
Q2 | $530K | Hold |
3,880
| – | – | 0.03% | 265 |
|
|
2020
Q1 | $418K | Sell |
3,880
-472
| -11% | -$50.8K | 0.03% | 256 |
|
|
2019
Q4 | $524K | Sell |
4,352
-187
| -4% | -$22.5K | 0.03% | 266 |
|
|
2019
Q3 | $452K | Hold |
4,539
| – | – | 0.03% | 287 |
|
|
2019
Q2 | $495K | Buy |
4,539
+10
| +0.2% | +$1.09K | 0.03% | 286 |
|
|
2019
Q1 | $506K | Hold |
4,529
| – | – | 0.03% | 293 |
|
|
2018
Q4 | $437K | Sell |
4,529
-773
| -15% | -$74.6K | 0.03% | 327 |
|
|
2018
Q3 | $647K | Buy |
5,302
+905
| +21% | +$110K | 0.04% | 297 |
|
|
2018
Q2 | $483K | Buy |
4,397
+145
| +3% | +$15.9K | 0.03% | 374 |
|
|
2018
Q1 | $454K | Buy |
4,252
+5
| +0.1% | +$534 | 0.03% | 338 |
|
|
2017
Q4 | $453K | Buy |
4,247
+2,826
| +199% | +$301K | 0.03% | 323 |
|
|
2017
Q3 | $474K | Buy |
1,421
+45
| +3% | +$15K | 0.04% | 219 |
|
|
2017
Q2 | $427K | Buy |
1,376
+5
| +0.4% | +$1.55K | 0.03% | 216 |
|
|
2017
Q1 | $402K | Buy |
1,371
+40
| +3% | +$11.7K | 0.03% | 227 |
|
|
2016
Q4 | $353K | Buy |
1,331
+489
| +58% | +$130K | 0.03% | 230 |
|
|
2016
Q3 | $244K | Buy |
+842
| New | +$244K | 0.02% | 283 |
|